The identification of transcriptional regulators (TRs), including transcription factors (TFs) and chromatin regulators (CRs), that control oncogenic gene expression program in each cancer type is an essential task for cancer research as these regulators could be targets for novel therapies. This evidence concerns the gene TWIST1 and cancer.